ESCAPE-NA1 Trial Brings Hope of Neuroprotective Drugs for Acute Ischemic Stroke – Highlights of the Phase 3 Clinical Trial on Nerinetide
Xin-Fu Zhou1
1 Health and Biomedical Innovation, Clinical and Health Sciences, University of South Australia, Adelaide, Australia
Abstract
Keywords
